Traws Pharma, Inc.TRAWNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank100
5Y CAGR+30.4%
Year-over-Year Change
Year-over-year net income growth rate
5Y CAGR
+30.4%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
3.8x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q2 2025 | 92.63% |
| Q4 2024 | -70.08% |
| Q2 2024 | 44.16% |
| Q4 2023 | 10.99% |
| Q2 2023 | 7.33% |
| Q4 2022 | -32.80% |
| Q2 2022 | -12.87% |
| Q4 2021 | 19.33% |
| Q2 2021 | 29.39% |
| Q4 2020 | -1.47% |
| Q2 2020 | -20.74% |
| Q4 2019 | 7.34% |
| Q2 2019 | -1.47% |
| Q4 2018 | -14.88% |
| Q2 2018 | 27.29% |
| Q4 2017 | -20.53% |
| Q2 2017 | -55.05% |
| Q4 2016 | 44.17% |
| Q2 2016 | -370.76% |
| Q4 2015 | 87.41% |
| Q2 2015 | 24.61% |
| Q4 2014 | 20.27% |
| Q2 2014 | -0.84% |
| Q4 2013 | -28.20% |
| Q2 2013 | -134.31% |
| Q4 2012 | 35.78% |
| Q2 2012 | 0.00% |